Valuation: Novartis AG

Market Cap 265B 229B 217B 196B 368B 25,380B 371B 2,586B 996B 12,875B 995B 973B 40,932B P/E 2026 *
19.7x
P/E 2027 * 16.6x
Enterprise Value 296B 257B 242B 220B 412B 28,407B 415B 2,894B 1,115B 14,411B 1,113B 1,089B 45,814B EV / Sales 2026 *
5.14x
EV / Sales 2027 * 4.77x
Free-Float
91.66%
Yield 2026 *
3.13%
Yield 2027 * 3.26%
1 day-0.39%
1 week+1.48%
Current month-7.95%
1 month-8.06%
3 months-5.62%
6 months-6.57%
Current year+3.52%
1 week 110.3
Extreme 110.3
116.04
1 month 110.3
Extreme 110.3
132.68
Current year 107.68
Extreme 107.68
132.68
1 year 96.03
Extreme 96.03
132.68
3 years 81.1
Extreme 81.1
132.68
5 years 72.84
Extreme 72.84
132.68
10 years 65.09
Extreme 65.09
132.68
Manager TitleAgeSince
Chief Executive Officer 50 31/01/2018
Director of Finance/CFO - 15/03/2026
Compliance Officer 58 13/04/2025
Director TitleAgeSince
Director/Board Member 67 31/12/2014
Director/Board Member 69 31/12/2015
Director/Board Member 61 31/12/2015
Date Insider Type Main position Quantity % Market Cap. Importance
18/05/26 Sell -5,200 0.0003%
04/05/26 Sell 6,800 0.0003%
17/02/26 Sell 30,743 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
-0.38%+1.48%+16.18%+22.98% 265B
+2.02%-0.96%+50.69%+92.40% 1,015B
+0.28%-3.24%+49.57%+62.65% 642B
+1.81%+2.07%+19.89%+70.38% 463B
-1.13%+1.94%+37.21%+36.71% 353B
-0.72%+1.65%+5.76%+10.35% 254B
+1.10%-12.75%+38.03%+45.44% 206B
-0.53%-4.47%-21.44%-58.15% 191B
+1.87%-3.04%+27.81%+89.26% 182B
0.00%-2.57%+16.13%-18.83% 158B
Average +0.30%-3.28%+23.98%+35.32% 372.82B
Weighted average by Cap. +0.40%-2.22%+32.90%+53.55%

Financials

2026 *2027 *
Net sales 57.64B 49.94B 47.13B 42.76B 80.21B 5,525B 80.79B 563B 217B 2,803B 216B 212B 8,910B 61.31B 53.13B 50.14B 45.49B 85.33B 5,877B 85.94B 599B 231B 2,981B 230B 225B 9,478B
Net income 14.19B 12.3B 11.6B 10.53B 19.75B 1,360B 19.89B 139B 53.4B 690B 53.3B 52.12B 2,194B 15.75B 13.64B 12.88B 11.68B 21.91B 1,509B 22.07B 154B 59.25B 766B 59.14B 57.84B 2,434B
Net Debt 31.58B 27.37B 25.83B 23.43B 43.95B 3,027B 44.27B 308B 119B 1,536B 119B 116B 4,882B 27.9B 24.17B 22.81B 20.69B 38.82B 2,674B 39.1B 272B 105B 1,356B 105B 102B 4,312B
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
15/09/26 CHF 113.38 -0.47% 415,354
14/09/26 CHF 113.92 +1.68% 3,025,084
11/09/26 CHF 112.04 -0.09% 2,803,406
10/09/26 CHF 112.14 +0.43% 3,279,444
09/09/26 CHF 111.66 -0.13% 4,317,913
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
23
Last Close Price
139.31USD
Average target price
153.34USD
Spread / Average Target
+10.07%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NOVN Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!